Drug Profile
Flotegatide F18
Alternative Names: RGD F18Latest Information Update: 01 Apr 2019
Price :
$50
*
At a glance
- Originator Siemens Medical Solutions Molecular Imaging
- Developer Assistance Publique Hopitaux de Paris; Siemens Medical Solutions Molecular Imaging
- Class Peptide diagnostics; Peptides; Radiopharmaceutical diagnostics
- Mechanism of Action Integrin alphaVbeta3 modulators; Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atherosclerosis; Cancer
Most Recent Events
- 01 Apr 2019 Discontinued - Phase-II for Cancer (Diagnosis) in France (IV)
- 01 Apr 2019 Discontinued - Preclinical for Atherosclerosis (Diagnosis) in USA (IV)